LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article ; Online: Perceived Need for Mental Health Services Among Healthcare Workers During the Coronavirus Disease-19 Pandemic in Turkey: A Multicenter Cross-sectional Study

    Sandal, Abdulsamet / Karadoğan, Dilek / Telatar, Tahsin Gökhan / Kotan, Abdurrahman / Bilgin Konyalıhatipoğlu, Esin / Yumrukuz Şenel, Merve / Karadeniz Güven, Damla / Hüseynova, Khurshud / Yalçın, Burcu / Asfuroğlu, Pelin / Ramaslı Gürsoy, Tuğba / Şişmanlar Eyüboğlu, Tuğba / Karakaş, Fatma Gülsüm / Köse, Neslihan / Kara, Kaan / Çelik, Selman / İlgar, Ceren / Yüksel, Aycan / Güner Zırıh, Neşe Merve /
    Selimoğlu, İnci / Gülhan, Pınar Yıldız / Erçelik, Merve / Cerit Çakır, Ahu / Çetin, Nazlı / Kaya, İlknur / Karaoğlanoğlu, Selen / Marım, Feride / Özden Sertçelik, Ümran / Uyar Er, Kübra / Özçelik, Neslihan / Ataoğlu, Özlem / Gültekin, Ökkeş / Er, Aslıhan Banu / Akgün, Metin

    Balkan medical journal

    2023  Volume 40, Issue 4, Page(s) 262–270

    Abstract: Background: The coronavirus disease-2019 pandemic has contributed to work-related psychosocial risks in healthcare workers.: Aims: To evaluate the perceived need for mental health services and related factors in Turkish healthcare workers practicing ... ...

    Abstract Background: The coronavirus disease-2019 pandemic has contributed to work-related psychosocial risks in healthcare workers.
    Aims: To evaluate the perceived need for mental health services and related factors in Turkish healthcare workers practicing in pandemic hospitals.
    Study design: Cross-sectional study.
    Methods: Data were collected from face-to-face interviews with healthcare workers at 19 pandemic hospitals in 13 provinces between September and November 2021. The study survey included the evaluation of the perceived need for and utilization of mental health services in the previous year, as well as sociodemographic, health-related, and work-related characteristics, the General Health Questionnaire-12, the World Health Organization Quality of Life-BREF (WHOQoL-BREF) questionnaire, and the Fear of coronavirus disease-2019 scale (FCV-19S).
    Results: Of 1,556 participants, 522 (33.5%) reported a perceived need for mental health services, but only 133 (8.5%) reported receiving these services. Multiple logistic regression analysis of the perceived need for mental health services revealed significant relationships with lower age, female sex, being a current smoker, having a chronic disease, having a mental disorder, coronavirus disease-2019 contact within the last three months in settings other than the home or workplace, a positive coronavirus disease-2019 vaccination history, being a physician, being a non-physician healthcare professional, and coronavirus disease-2019 contact within the last three months at work. After adjustment for these characteristics, higher General Health Questionnaire-12 and FCV-19S scores and lower WHOQoL-BREF domain scores were related to the perceived need for mental health services in logistic regression analyses.
    Conclusion: The findings indicate a substantial need for mental health services amongst Turkish healthcare workers during the pandemic and outline participants’ characteristics regarding high-priority groups for the intervention. Future research may focus on developing actions and evaluating their efficiency.
    MeSH term(s) Humans ; Female ; COVID-19 ; Cross-Sectional Studies ; Pandemics ; Turkey/epidemiology ; Quality of Life ; Health Personnel/psychology ; Mental Health Services
    Language English
    Publishing date 2023-04-19
    Publishing country Turkey
    Document type Multicenter Study ; Journal Article
    ZDB-ID 2612982-6
    ISSN 2146-3131 ; 2146-3131
    ISSN (online) 2146-3131
    ISSN 2146-3131
    DOI 10.4274/balkanmedj.galenos.2023.2022-12-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: COVID-19: vaccination vs. hospitalization.

    Uzun, Oguz / Akpolat, Tekin / Varol, Ayhan / Turan, Sema / Bektas, Serife Gokbulut / Cetinkaya, Pelin Duru / Dursun, Mazlum / Bakan, Nurten / Ketencioglu, Burcu Baran / Bayrak, Murat / Baris, Serap Argun / Guner, Rahmet / Gunal, Ozgur / Nural, Serkan / Deniz, Pelin Pinar / Toprak, Oya Baydar / Ozkan, Gulcihan / Gumus, Ayça / Kerget, Ferhan /
    Ercelik, Merve / Ataoglu, Ozlem / Yuksel, Aycan / Ates, Gungor / Kutsoylu, Oya Eren / Kose, Neslihan / Kizilirmak, Deniz / Keskin, Serdar / Gultekin, Okkes / Coskun, Nilüfer / Yilmaz, Emine Serap / Uslu, Selen / Basyigit, İlknur / Ergan, Begüm / Deveci, Figen / Yakar, Mehmet Nuri / Zuhur, Cigdem / Sagcan, Gulseren / Yuce, Zeynep Ture / Kuluozturk, Mutlu / Sezgin, Mehmet Emin / Sezgin, Esma Nur Aktepe / Havlucu, Yavuz / Cuhadaroglu, Caglar / Kilinc, Oguz / Boyaci, Hasim / Altunay, Hayriye / Akti, Mehmet / Dursun, Zehra Bastepe / Kalem, Ayse Kaya / Isik, Sinem Akkaya / Akyildiz, Levent / Aykac, Nilüfer / Almaz, Mehmet Selim / Kokturk, Nurdan / Itil, Oya

    Infection

    2022  Volume 50, Issue 3, Page(s) 747–752

    Abstract: Objective: Vaccination is the most efficient way to control the coronavirus disease 2019 (COVID-19) pandemic, but vaccination rates remain below the target level in most countries. This multicenter study aimed to evaluate the vaccination status of ... ...

    Abstract Objective: Vaccination is the most efficient way to control the coronavirus disease 2019 (COVID-19) pandemic, but vaccination rates remain below the target level in most countries. This multicenter study aimed to evaluate the vaccination status of hospitalized patients and compare two different booster vaccine protocols.
    Setting: Inoculation in Turkey began in mid-January 2021. Sinovac was the only available vaccine until April 2021, when BioNTech was added. At the beginning of July 2021, the government offered a third booster dose to healthcare workers and people aged > 50 years who had received the two doses of Sinovac. Of the participants who received a booster, most chose BioNTech as the third dose.
    Methods: We collected data from 25 hospitals in 16 cities. Patients hospitalized between August 1 and 10, 2021, were included and categorized into eight groups according to their vaccination status.
    Results: We identified 1401 patients, of which 529 (37.7%) were admitted to intensive care units. Nearly half (47.8%) of the patients were not vaccinated, and those with two doses of Sinovac formed the second largest group (32.9%). Hospitalizations were lower in the group which received 2 doses of Sinovac and a booster dose of BioNTech than in the group which received 3 doses of Sinovac.
    Conclusion: Effective vaccinations decreased COVID-19-related hospitalizations. The efficacy after two doses of Sinovac may decrease over time; however, it may be enhanced by adding a booster dose. Moreover, unvaccinated patients may be persuaded to undergo vaccination.
    MeSH term(s) COVID-19/epidemiology ; COVID-19/prevention & control ; COVID-19 Vaccines ; Hospitalization ; Humans ; SARS-CoV-2 ; Vaccination ; Vaccines
    Chemical Substances COVID-19 Vaccines ; Vaccines
    Language English
    Publishing date 2022-01-04
    Publishing country Germany
    Document type Journal Article ; Multicenter Study
    ZDB-ID 185104-4
    ISSN 1439-0973 ; 0300-8126 ; 0173-2129
    ISSN (online) 1439-0973
    ISSN 0300-8126 ; 0173-2129
    DOI 10.1007/s15010-021-01751-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: The association of antiviral drugs with COVID-19 morbidity: The retrospective analysis of a nationwide COVID-19 cohort.

    Babayigit, Cenk / Kokturk, Nurdan / Kul, Seval / Cetinkaya, Pelin Duru / Atis Nayci, Sibel / Argun Baris, Serap / Karcioglu, Oguz / Aysert, Pinar / Irmak, Ilim / Akbas Yuksel, Aycan / Sekibag, Yonca / Baydar Toprak, Oya / Azak, Emel / Mulamahmutoglu, Sait / Cuhadaroglu, Caglar / Demirel, Aslihan / Kerget, Bugra / Baran Ketencioglu, Burcu / Ozger, Hasan Selcuk /
    Ozkan, Gulcihan / Ture, Zeynep / Ergan, Begum / Avkan Oguz, Vildan / Kilinc, Oguz / Ercelik, Merve / Ulukavak Ciftci, Tansu / Alici, Ozlem / Nurlu Temel, Esra / Ataoglu, Ozlem / Aydin, Asena / Cetiner Bahcetepe, Dilek / Gullu, Yusuf Taha / Fakili, Fusun / Deveci, Figen / Kose, Neslihan / Tor, Muge Meltem / Gunluoglu, Gulsah / Altin, Sedat / Turgut, Teyfik / Tuna, Tibel / Ozturk, Onder / Dikensoy, Oner / Yildiz Gulhan, Pinar / Basyigit, Ilknur / Boyaci, Hasim / Oguzulgen, Ipek Kivilcim / Borekci, Sermin / Gemicioglu, Bilun / Bayraktar, Firat / Elbek, Osman / Hanta, Ismail / Kuzu Okur, Hacer / Sagcan, Gulseren / Uzun, Oguz / Akgun, Metin / Altinisik, Goksel / Dursun, Berna / Cakir Edis, Ebru / Gulhan, Erkmen / Oner Eyuboglu, Fusun / Gultekin, Okkes / Havlucu, Yavuz / Ozkan, Metin / Sakar Coskun, Aysin / Sayiner, Abdullah / Kalyoncu, A Fuat / Itil, Oya / Bayram, Hasan

    Frontiers in medicine

    2022  Volume 9, Page(s) 894126

    Abstract: Background and objectives: Although several repurposed antiviral drugs have been used for the treatment of COVID-19, only a few such as remdesivir and molnupiravir have shown promising effects. The objectives of our study were to investigate the ... ...

    Abstract Background and objectives: Although several repurposed antiviral drugs have been used for the treatment of COVID-19, only a few such as remdesivir and molnupiravir have shown promising effects. The objectives of our study were to investigate the association of repurposed antiviral drugs with COVID-19 morbidity.
    Methods: Patients admitted to 26 different hospitals located in 16 different provinces between March 11-July 18, 2020, were enrolled. Case definition was based on WHO criteria. Patients were managed according to the guidelines by Scientific Board of Ministry of Health of Turkey. Primary outcomes were length of hospitalization, intensive care unit (ICU) requirement, and intubation.
    Results: We retrospectively evaluated 1,472 COVID-19 adult patients; 57.1% were men (mean age = 51.9 ± 17.7years). A total of 210 (14.3%) had severe pneumonia, 115 (7.8%) were admitted to ICUs, and 69 (4.7%) were intubated during hospitalization. The median (interquartile range) of duration of hospitalization, including ICU admission, was 7 (5-12) days. Favipiravir (
    Conclusion: Our findings demonstrated that antiviral drugs including lopinavir, ritonavir, and favipiravir were associated with negative clinical outcomes such as increased risks for lengthy hospital stay, ICU admission, and invasive mechanical ventilation requirement. Therefore, repurposing such agents without proven clinical evidence might not be the best approach for COVID-19 treatment.
    Language English
    Publishing date 2022-08-31
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2775999-4
    ISSN 2296-858X
    ISSN 2296-858X
    DOI 10.3389/fmed.2022.894126
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: COVID-19 Pandemic and the Global Perspective of Turkish Thoracic Society.

    Köktürk, Nurdan / İtil, Bahriye Oya / Altınışık, Göksel / Adıgüzel, Nalan / Akgün, Metin / Akyıldız, Levent / Altın, Sedat / Arıkan, Hüseyin / Ateş, Güngör / Ay, Pınar / Aykaç, Nilüfer / Babayiğit, Cenk / Bostan, Pınar / Cinel, Güzin / Çalışır, Haluk Celaleddin / Çelik, Pınar / Çetinkaya, Pelin Duru / Dağlı, Elif / Demir, Ahmet Uğur /
    Demir, Canan / Dikensoy, Öner / Edis, Ebru Çakır / Elbek, Osman / Erdinç, Münevver / Ergan, Begüm / Eyüboğlu, A Füsun Öner / Gemicioğlu, Bilun / Göksel, Tuncay / Gülhan, Erkmen / Gültekin, Ökkeş / Gürkan, Canan Gündüz / Gürgün, Alev / Havlucu, Yavuz / Başoğlu, Ozen K / Karakurt, Sait / Karakurt, Zuhal / Kılınç, Oğuz / Kocabaş, Ali / Kul, Seval / Müsellim, Benan / Naycı, Sibel / Özkan, Metin / Pınarer, Özgün / Saltürk, Cüneyt / Sandal, Abdulsamet / Sayıner, Abdullah / Şen, Elif / Şimşek, Gökçen Ömeroğlu / Karadağ, Bülent Taner / Akyıl, Fatma Tokgöz / Töreyin, Zehra Nur / Uçan, Eyüp Sabri / Küçük, Filiz Çağla Uyanusta / Varol, Ayhan / Yasin, Yeşim / Yıldız, Tekin / Yorgancıoğlu, A Arzu / Bayram, Hasan

    Turkish thoracic journal

    2020  Volume 21, Issue 6, Page(s) 419–432

    Abstract: It has been more than 3 months now since the first case of COVID-19 was reported in Turkey. Globally, the number of confirmed cases and deaths reached 9,653,048 and 491,128 respectively, as reported by 216 countries by June 27, 2020. Turkey had 1,396 new ...

    Abstract It has been more than 3 months now since the first case of COVID-19 was reported in Turkey. Globally, the number of confirmed cases and deaths reached 9,653,048 and 491,128 respectively, as reported by 216 countries by June 27, 2020. Turkey had 1,396 new cases, 194,511 total cases, and 5,065 deaths by the same date. From the first case until today, the Turkish Thoracic Society (TTS) has been very proactive in educating doctors, increasing public awareness, undertaking academic studies, and assisting with public health policies. In the present report, social, academic, and management perspectives of the pandemic are presented under appropriate subtitles. During this critical public health crisis, TTS has once again demonstrated its readiness and constructive stance by supporting public health, healthcare workers, and the environment. This review summarizes the perspective of TTS on each aspect of the COVID-19 pandemic and casts light on its contributions.
    Language English
    Publishing date 2020-11-01
    Publishing country Turkey
    Document type Journal Article ; Review
    ISSN 2149-2530
    ISSN (online) 2149-2530
    DOI 10.5152/TurkThoracJ.2020.20174
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients.

    Kokturk, Nurdan / Babayigit, Cenk / Kul, Seval / Duru Cetinkaya, Pelin / Atis Nayci, Sibel / Argun Baris, Serap / Karcioglu, Oguz / Aysert, Pinar / Irmak, Ilim / Akbas Yuksel, Aycan / Sekibag, Yonca / Baydar Toprak, Oya / Azak, Emel / Mulamahmutoglu, Sait / Cuhadaroglu, Caglar / Demirel, Aslihan / Kerget, Bugra / Baran Ketencioglu, Burcu / Ozger, Hasan Selcuk /
    Ozkan, Gulcihan / Ture, Zeynep / Ergan, Begum / Avkan Oguz, Vildan / Kilinc, Oguz / Ercelik, Merve / Ulukavak Ciftci, Tansu / Alici, Ozlem / Nurlu Temel, Esra / Ataoglu, Ozlem / Aydin, Asena / Cetiner Bahcetepe, Dilek / Gullu, Yusuf Taha / Fakili, Fusun / Deveci, Figen / Kose, Neslihan / Tor, Muge Meltem / Gunluoglu, Gulsah / Altin, Sedat / Turgut, Teyfik / Tuna, Tibel / Ozturk, Onder / Dikensoy, Oner / Yildiz Gulhan, Pinar / Basyigit, Ilknur / Boyaci, Hasim / Oguzulgen, I Kivilcim / Borekci, Sermin / Gemicioglu, Bilun / Bayraktar, Firat / Elbek, Osman / Hanta, Ismail / Kuzu Okur, Hacer / Sagcan, Gulseren / Uzun, Oguz / Akgun, Metin / Altinisik, Goksel / Dursun, Berna / Cakir Edis, Ebru / Gulhan, Erkmen / Oner Eyuboglu, Fusun / Gultekin, Okkes / Havlucu, Yavuz / Ozkan, Metin / Sakar Coskun, Aysin / Sayiner, Abdullah / Kalyoncu, Ali Fuat / Itil, Oya / Bayram, Hasan

    Respiratory medicine

    2021  Volume 183, Page(s) 106433

    Abstract: The COVID-19-related death rate varies between countries and is affected by various risk factors. This multicenter registry study was designed to evaluate the mortality rate and the related risk factors in Turkey. We retrospectively evaluated 1500 adults ...

    Abstract The COVID-19-related death rate varies between countries and is affected by various risk factors. This multicenter registry study was designed to evaluate the mortality rate and the related risk factors in Turkey. We retrospectively evaluated 1500 adults with COVID-19 from 26 centers who were hospitalized between March 11 and July 31, 2020. In the study group, 1041 and 459 cases were diagnosed as definite and highly probable cases, respectively. There were 993 PCR-positive cases (66.2%). Among all cases, 1144 (76.3%) were diagnosed with non-severe pneumonia, whereas 212 (14.1%) had severe pneumonia. Death occurred in 67 patients, corresponding to a mortality rate of 4.5% (95% CI:3.5-5.6). The univariate analysis demonstrated that various factors, including male sex, age ≥65 years and the presence of dyspnea or confusion, malignity, chronic obstructive lung disease, interstitial lung disease, immunosuppressive conditions, severe pneumonia, multiorgan dysfunction, and sepsis, were positively associated with mortality. Favipiravir, hydroxychloroquine and azithromycin were not associated with survival. Following multivariate analysis, male sex, severe pneumonia, multiorgan dysfunction, malignancy, sepsis and interstitial lung diseases were found to be independent risk factors for mortality. Among the biomarkers, procalcitonin levels on the 3rd-5th days of admission showed the strongest associations with mortality (OR: 6.18; 1.6-23.93). This study demonstrated that the mortality rate in hospitalized patients in the early phase of the COVID-19 pandemic was a serious threat and that those patients with male sex, severe pneumonia, multiorgan dysfunction, malignancy, sepsis and interstitial lung diseases were at increased risk of mortality; therefore, such patients should be closely monitored.
    MeSH term(s) Aged ; COVID-19/mortality ; Female ; Humans ; Male ; Middle Aged ; Pandemics ; Population Surveillance ; Retrospective Studies ; Risk Factors ; Survival Rate/trends ; Turkey/epidemiology
    Language English
    Publishing date 2021-04-28
    Publishing country England
    Document type Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 1003348-8
    ISSN 1532-3064 ; 0954-6111
    ISSN (online) 1532-3064
    ISSN 0954-6111
    DOI 10.1016/j.rmed.2021.106433
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top